Strength of hip muscles and bradykinesia contribute to walking speed over a long distance, but not a short distance, in people with mild Parkinson's disease: An observational study.


Journal

Gait & posture
ISSN: 1879-2219
Titre abrégé: Gait Posture
Pays: England
ID NLM: 9416830

Informations de publication

Date de publication:
02 2023
Historique:
received: 17 05 2022
revised: 03 11 2022
accepted: 30 11 2022
pubmed: 13 12 2022
medline: 3 3 2023
entrez: 12 12 2022
Statut: ppublish

Résumé

Bradykinesia and postural instability contribute to walking limitations in people with Parkinson's disease (PD), but the contribution of muscle strength to walking speed has not been examined extensively. Does strength of the major lower limb muscles contribute to walking speed over short and long distances in people with PD? na. A cross-sectional, observational study. 50 people with mild PD. Maximum isometric strength of the flexors and extensors of the lower limb was measured using hand-held dynamometry. Flexed posture, postural instability and bradykinesia were measured using the MDS-UPDRS part III. Walking speed was measured during the 10-m Walk Test and 6-min Walk Test. Univariate analysis revealed that age, bradykinesia, flexed posture, and hip, knee and ankle weakness were all significantly correlated with walking speed over short and long distances. Multiple regression analysis revealed that age, bradykinesia, flexed posture and weakness of the hip and knee muscles together accounted for 47% of the variance in walking speed over a short distance, with age (R In people with mild PD, weakness of the hip muscles and bradykinesia only make a significant relative contribution to walking speed over a long distance. Therefore, in people with normal walking speed over a short distance the 6-min Walk Test could be measured to more effectively identify the impact of motor impairments on walking.

Sections du résumé

BACKGROUND
Bradykinesia and postural instability contribute to walking limitations in people with Parkinson's disease (PD), but the contribution of muscle strength to walking speed has not been examined extensively.
RESEARCH QUESTION
Does strength of the major lower limb muscles contribute to walking speed over short and long distances in people with PD?
METHOD
na.
DESIGN
A cross-sectional, observational study.
PARTICIPANTS
50 people with mild PD.
OUTCOME MEASURES
Maximum isometric strength of the flexors and extensors of the lower limb was measured using hand-held dynamometry. Flexed posture, postural instability and bradykinesia were measured using the MDS-UPDRS part III. Walking speed was measured during the 10-m Walk Test and 6-min Walk Test.
RESULTS
Univariate analysis revealed that age, bradykinesia, flexed posture, and hip, knee and ankle weakness were all significantly correlated with walking speed over short and long distances. Multiple regression analysis revealed that age, bradykinesia, flexed posture and weakness of the hip and knee muscles together accounted for 47% of the variance in walking speed over a short distance, with age (R
SIGNIFICANCE
In people with mild PD, weakness of the hip muscles and bradykinesia only make a significant relative contribution to walking speed over a long distance. Therefore, in people with normal walking speed over a short distance the 6-min Walk Test could be measured to more effectively identify the impact of motor impairments on walking.

Identifiants

pubmed: 36508883
pii: S0966-6362(22)00698-1
doi: 10.1016/j.gaitpost.2022.11.061
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-106

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest All authors declare that they have no actual or perceived conflict of interest.

Auteurs

E Preston (E)

University of Canberra, Guraguma St, Bruce, ACT 2617, Australia. Electronic address: Elisabeth.preston@canberra.edu.au.

R Salmon (R)

University of Canberra, Guraguma St, Bruce, ACT 2617, Australia.

N de Meillon (N)

University of Canberra, Guraguma St, Bruce, ACT 2617, Australia.

M Boom (M)

University of Canberra, Guraguma St, Bruce, ACT 2617, Australia.

L Ada (L)

University of Sydney, Susan Wakil Health Building, Western Avenue, NSW 2006, Australia.

N Mahendran (N)

University of Canberra, Guraguma St, Bruce, ACT 2617, Australia.

A Flynn (A)

University of Canberra, Guraguma St, Bruce, ACT 2617, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH